2016-03-15T00:00:00.000-04:00
Piper Jaffray,0.223825
Exchange Commission,0.38093
recent quarter,0.421076
breakthrough cancer pain,-0.557509
InvestorPlace Broker Center,0.555736
Therapeutics Inc Daily,0.435908
Janus Capital Management,0.421076
12-month high,-0.43462
sell rating,0.346521
personal trading style,0.598412
target price,-0.406953
supportive care products,0.79687
AnalystRatingsNetwork.com reports,-0.278923
legal filing,-0.245224
average price,0.17779
shares,0.00864871
consensus estimate,0.342805
concise daily summary,0.518559
approved second-line treatment,-0.520021
sublingual fentanyl spray,-0.557509
quarterly revenue,-0.380228
chemotherapy-induced nausea,-0.520021
stock broker,0.245696
consensus rating,0.385271
Director Patrick Fourteau,-0.260802
Insys Therapeutics,0.0480272
recent Form,0.38093
rating,0.365896
research analyst,0.346521
